Live Markets

Loading markets...

#Depression

Eli Lilly

Eli Lilly's AtaiBeckley Acquisition: A $3.8B Psychedelic Leap

July 17, 2026

iTBS Depression Treatment Breakthrough 2026: New JAMA Study

iTBS Depression Treatment Breakthrough 2026: New JAMA Study

July 12, 2026

FDA-Bound Psilocybin Therapy Shows Lasting Relief for Depression

FDA-Bound Psilocybin Therapy Shows Lasting Relief for Depression

July 07, 2026

LSD Depression Clinical Trial: DT120 Pill Shines in Phase 3

LSD Depression Clinical Trial: DT120 Pill Shines in Phase 3

June 24, 2026

Paid Paternity Leave Crucial for Dads

Paid Paternity Leave Crucial for Dads' Mental Health: New Study

June 19, 2026

Childhood Sleep and Teen Depression: Study Reveals Double Risk

Childhood Sleep and Teen Depression: Study Reveals Double Risk

June 09, 2026

FDA Psychedelic Fast Track: 2026 Mandate Accelerates Therapies

FDA Psychedelic Fast Track: 2026 Mandate Accelerates Therapies

May 02, 2026

FDA Psychedelic Approval 2026: Fast-Tracking PTSD & Depression Cures

FDA Psychedelic Approval 2026: Fast-Tracking PTSD & Depression Cures

April 29, 2026

Parental Depression and Child Development: A 30-Year Impact Study

Parental Depression and Child Development: A 30-Year Impact Study

April 16, 2026

woman sitting beside drawer

Parental Depression Timing Study 2026 Reveals Lifelong Impact

April 15, 2026

PreviousPrev
1
2
3
4
5
...
12
NextNext